Cargando…
Acarbose Use and Liver Injury in Diabetic Patients With Severe Renal Insufficiency and Hepatic Diseases: A Propensity Score-Matched Cohort Study
Background: Acarbose has been deemed contraindicated in diabetic patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD), but such use is not uncommon. We tested whether this concept hold true in this population with different background hepatic diseases. Methods: All incident d...
Autores principales: | Chao, Chia-Ter, Wang, Jui, Huang, Jenq-Wen, Chien, Kuo-Liong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090209/ https://www.ncbi.nlm.nih.gov/pubmed/30131698 http://dx.doi.org/10.3389/fphar.2018.00860 |
Ejemplares similares
-
The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis
por: Chao, Chia-Ter, et al.
Publicado: (2021) -
Frailty Predicts an Increased Risk of End-Stage Renal Disease with Risk Competition by Mortality among 165,461 Diabetic Kidney Disease Patients
por: Chao, Chia-Ter, et al.
Publicado: (2019) -
Frailty modifies the association between opioid use and mortality in chronic kidney disease patients with diabetes: a population-based cohort study
por: Lee, Szu-Ying, et al.
Publicado: (2020) -
Frailty predicts a higher risk of incident urolithiasis in 525 368 patients with diabetes mellitus: a population-based study
por: Chao, Chia-Ter, et al.
Publicado: (2020) -
Frailty increases the risk for developing urinary tract infection among 79,887 patients with diabetic mellitus and chronic kidney disease
por: Chao, Chia-Ter, et al.
Publicado: (2021)